Yes...never argue with the Village Idiot who has a keyboard but can't read or do any DD
Looking at slide 20 in HRT's Q4 2012 results, revenue was 108,000,000 BRL or ~ $54,000,000 USD. I assume that's MM's research lab he folded into HRT public share structure + a wee bit of interest from the IPO cash
X that by 4 Q's = > $200,000,000 USSD for 2012
Maybe not a lot of revenue to the dougheads here that don't know what revenue is, but that's a chunk of change.
Is MM worth $6M a year for bringing that coin here? I'd rather pay MM for his PhD dominated lab than the Hedgies that swarm like parasites and post mis-information here. Whopper after whopper and a bunch more on a great news day.
So for Q1 2013...add in the oil revenue, hopefully MM burned the shorters with retroactive revenue to Jan 1 2013. Sweet
Only thing better would be a Rights offering....shorters have to provide like a div when short.